author-photo

Georg Kreuzbauer

Amgen

14

Papers

117

Citations

Citation Trend

Filter By

Papers (11) Sort By

Journal Conference Others

Real-World Effectiveness and Safety of Blinatumomab in Adults with Relapsed or Refractory B-Cell Precursor Acute Lymphoblastic Leukaemia in Europe: 3-Year Results in Philadelphia Chromosome-Negative Patients and a Subset of Patients with Late First Relapse

2020 Blood
Show All
- Source
- Cite
- Save
Citations (1)
Treatment of Adults with Relapsed/Refractory Philadelphia Chromosome Negative Acute Lymphoblastic Leukemia with Blinatumomab in a Real-World Setting: Results from the Neuf Study

2019 Blood
Show All
- Source
- Cite
- Save
Citations (0)
A systematic literature review and meta-analysis of minimal residual disease as a prognostic indicator in adult B-cell acute lymphoblastic leukemia

2019 Haematologica
Show All
- Source
- Cite
- Save
Citations (34)
Treatment of Adults with Minimal Residual Disease (MRD) Positive Acute Lymphoblastic Leukemia with Blinatumomab in a Real-World Setting: Results from the Neuf Study

2019 Blood
Show All
- Source
- Cite
- Save
Citations (0)
A large observational study of patients with primary immune thrombocytopenia receiving romiplostim in European clinical practice.

2017 European Journal of Haematology
Show All
- Source
- Cite
- Save
Citations (28)
Contents Vol. 134, 2015

2015 Acta Haematologica
Show All
- Source
- Cite
- Save
Citations (0)
Romiplostim Treatment in Adults with Immune Thrombocytopenia of Varying Duration and Severity

2015 Acta Haematologica
Show All
- Source
- Cite
- Save
Citations (15)
Impact of self-administration of romiplostim by patients with chronic immune thrombocytopenia compared with administration by a healthcare provider

2015 European Journal of Haematology
Show All
- Source
- Cite
- Save
Citations (8)
Romiplostim for the Treatment of Adults with Primary Immune Thrombocytopenia (ITP) in Routine Clinical Practice – Interim Results From a Large, European, Observational Study

2012 Blood
Show All
- Source
- Cite
- Save
Citations (2)
Romiplostim for the Treatment of Adults with Primary Immune Thrombocytopenia (ITP) in Routine Clinical Practice in France – Interim Results From a Large Observational Study

2012 Blood
Show All
- Source
- Cite
- Save
Citations (0)